Achieve Life Sciences is trading at $7.21, up 5.26%, with no clear same-day company or sector catalyst identified.
- Available company news shows no new announcement dated October 29.
- The latest listed company release was October 21, reporting 52-week cytisinicline results presented at CHEST 2026; it does not establish a direct catalyst for this session’s rise.
- Major U.S. indices are reported lower, so broad-market strength does not explain the gain.